Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 15.18B 2.24B 1.97B 1.83B 1.68B 3.16B 216B 3.21B 21.75B 8.5B 106B 8.42B 8.24B 367B P/E 2026 *
29.2x
P/E 2027 * -147x
Enterprise Value 15.18B 2.24B 1.97B 1.83B 1.68B 3.16B 216B 3.21B 21.75B 8.5B 106B 8.42B 8.24B 367B EV / Sales 2026 *
14.1x
EV / Sales 2027 * 12.1x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day-4.73%
1 week-7.69%
Current month-9.20%
1 month+4.12%
3 months-9.71%
6 months-8.49%
Current year+0.89%
1 week 33.5
Extreme 33.5
37.85
1 month 31.99
Extreme 31.99
44.8
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
81.48
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.5778
81.48
Manager TitleAgeSince
Chief Executive Officer 52 10/11/2015
Director of Finance/CFO 60 10/11/2015
Investor Relations Contact 38 30/12/2020
Director TitleAgeSince
Director/Board Member 70 30/06/2024
Chairman 52 10/11/2015
Director/Board Member 58 10/11/2015
Date Insider Type Main position Quantity % Market Cap.
05/01/26 Buy

Director

4,200 0.0010%
24/11/25 Buy

Director

7,000 0.0017%
01/09/23 Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-4.73%-7.69%-53.03%+20.59% 2.24B
+1.68%+0.88%+15.95%+73.90% 48.36B
+1.52%+2.21%+61.55%+111.64% 35.8B
-0.09%-2.23%-10.34%+20.31% 11.83B
-0.05%-3.55%+13.07%+70.62% 11.48B
-0.28%-0.37%+37.53%+142.08% 9.01B
+0.18%+1.77%+47.40%-8.43% 6.99B
+1.46%-1.09%+12.92%+33.48% 6.7B
+0.18%-1.94%+2.41%+167.04% 6.42B
-7.92%-13.61%-33.87%-3.30% 5.3B
Average -0.80%-2.60%+9.36%+62.79% 14.41B
Weighted average by Cap. +0.63%-0.55%+24.11%+77.49%

Financials

2026 *2027 *
Net sales 1.08B 160M 140M 130M 120M 225M 15.36B 228M 1.55B 604M 7.55B 599M 586M 26.11B 1.26B 186M 163M 152M 139M 262M 17.89B 266M 1.8B 704M 8.8B 697M 682M 30.41B
Net income 526M 77.68M 68.23M 63.45M 58.23M 109M 7.48B 111M 753M 294M 3.68B 292M 285M 12.72B -102M -15.06M -13.23M -12.3M -11.29M -21.21M -1.45B -21.54M -146M -57.08M -713M -56.55M -55.33M -2.47B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
24/07/26 CN¥33.85 -4.73% 10,301,233
23/07/26 CN¥35.53 -1.31% 9,608,287
22/07/26 CN¥36.00 -2.91% 13,663,622
21/07/26 CN¥37.08 +1.87% 16,486,924
20/07/26 CN¥36.40 -0.74% 13,121,235

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock